🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the amount of tirzepatide that gets...
Status
Completed
Location
Lilly Nus Centre for Clin Pharmacology
Start Date
2019-08-19
Trial ID
NCT04004988
Treatments Being Tested
The purpose of this study is to evaluate the usability of an auto-injector ...
Status
Completed
Location
Henry Ford Health System
Start Date
2016-04
Trial ID
NCT02722044
Treatments Being Tested
The primary objective of this study is to demonstrate equivalence of the ph...
Status
Completed
Location
PRA Health Sciences (PRA) - Early Development Services (EDS)
Start Date
2019-07-15
Trial ID
NCT04018599
Treatments Being Tested
The primary purpose of this study is to demonstrate the bioequivalence (BE)...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2022-09-06
Trial ID
NCT05533801
This study is a single-center, randomized, open-label, single-dose, paralle...
Status
Completed
Location
Zhengzhou Sixth People's Hospital
Start Date
2024-12-20
Trial ID
NCT06732973
Treatments Being Tested
This is a randomized, 2-part, 2-arm, open-label, parallel-group, multi-cent...
Status
Completed
Location
Covance Research Unit - Daytona
Start Date
2016-12-07
Trial ID
NCT02996019
Treatments Being Tested
Clinical trial to evaluate Usability of Subcutaneous Auto-injector of CT-P1...
Status
Completed
Location
Nasz Lekarz Osrodek Badan Klinicznych
Start Date
2019-09-09
Trial ID
NCT04171414
Treatments Being Tested
This study will assess the pharmacokinetic (PK) and safety of a single 0.8 ...
Status
Completed
Location
QOPK Phase 1 Clinic
Start Date
2016-01
Trial ID
NCT02675023
Treatments Being Tested
The purpose of the study is to evaluate the ability of subjects with modera...
Status
Completed
Location
Dv0002 946
Start Date
2018-12-20
Trial ID
NCT03766685
Treatments Being Tested
This study is being done to learn more about evolocumab in Chinese people w...
Status
Terminated
Location
Peking University Third Hospital
Start Date
2019-05-09
Trial ID
NCT03433755
Treatments Being Tested